Torthaí cuardaigh - Pamela Lockbaum

  • 1 - 2 toradh as 2 á dtaispeáint
Beachtaigh na torthaí
  1. 1
    Safety, Pharmacokinetics, and Activity of ABX-EGF, a Fully Human Anti–Epidermal Growth Factor Receptor Monoclonal Antibody in Patients With Metastatic Renal Cell Cancer

    Safety, Pharmacokinetics, and Activity of ABX-EGF, a Fully Human Anti–Epidermal Growth Factor Receptor Monoclonal Antibody in Patients With Metastatic Renal Cell Cancer de réir Eric K. Rowinsky, Garry Schwartz, Jared Gollob, John A. Thompson, Nicholas J. Vogelzang, Robert A. Figlin, Ronald M. Bukowski, Naomi B. Haas, Pamela Lockbaum, Yu-Ping Li, Rosalin Arends, Kenneth A. Foon, Gisela Schwab, Janice Dutcher

    Foilsithe / Cruthaithe 2004
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    A new form of Filgrastim with sustained duration in vivo and enhanced ability to mobilize PBPC in both mice and humans

    A new form of Filgrastim with sustained duration in vivo and enhanced ability to mobilize PBPC in both mice and humans de réir Graham Molineux, Olaf Kinstler, Bob Briddell, Cynthia Hartley, Patricia McElroy, Patrick J. Kerzic, Weston Sutherland, Greg Stoney, Brent Kern, Frederick A. Fletcher, Art Cohen, Elliot Korach, Tom Ulich, Ian McNiece, Pamela Lockbaum, Mary Ann Miller‐Messana, Sheila Gardner, Thomas R. Hunt, G Schwab

    Foilsithe / Cruthaithe 1999
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: